MITA, AdvaMed and MDMA Urge Congress to Repeal Job-Killing Device TaxContinue reading
Tag Archives: advamed
AdvaMed Study Reports MedTech Prices Remain Consistently Low Over Two Decades
Spending on MedTech Remains at Roughly 6 Percent of NHE Continue reading
Regenesis CEO Virginia Rybski Chats with Beaker.com
Regenesis Biomedical’s CEO, Virginia Rybski, chats with the team at Beaker.com on her expereince at AdvaMed 2011 as well as shares a story of growth and progress.Continue reading
AdvaMed explains the need for Medical Device Tax Repeal and Potential Job Impact
AdvaMed’s Stephen J. Ubl Shares Comments Regarding the Release of Proposed IRS Regs to Implement Medical Device Tax and Underscores Need for Swift RepealContinue reading
Regenesis Biomedical takes to the stage at the AdvaMed 2011 MedTech
Regenesis Biomedical to Participate in the AdvaMed 2011 MedTech Conference: Selected to present in the Wound Management category and serve as a panelist on Emerging Growth Companies.
Scottsdale, Arizona, September 5, 2011 — Regenesis Biomedical, Inc., a medical technology company focused on regenerative medicine, announced today that it was selected to present at the AdvaMed 2011 MedTech conference. Regenesis presents in the Wound Management category. The aim of the conference is to connect companies that have an innovative medical technology to parties interested in investing capital, partnering, or initiating strategic alliances.Continue reading
Study: Medical Device Tax Could Cost Jobs, Stifle Innovation
WASHINGTON,D.C. –The medical device tax, if implemented, could cost tens of thousands of jobs, almost double the industry’s total taxes, raise the effective tax rate to among the highest in the world, and harm U.S. competiveness, according to a study released today by the Advanced Medical Technology Association (AdvaMed). The new study, “Employment Effects of the New Excise Tax on the Medical Device Industry,” by Manhattan Institute senior fellow Diana Furchtgott-Roth and Hudson Institute senior fellow Harold Furchtgott-Roth, outlines a number of economic harms likely to result from the tax.Continue reading
AdvaMed 2011 creates opportunity for investment and partnerships
An increasing number of investors are coming to AdvaMed 2011: The MedTech Conference.
AdvaMed has posted the names of the key executives and investors attending and are adding more to the more confirmed names every day. Click here to view the list of executives who have committed to attend the event thus far.
AdvaMed 2011 Issues Call for Company Presentations
Innovative medical technology companies in all stages of development are eligible to apply to make a 9-minute business development presentation during AdvaMed 2011: The MedTech Conference. The conference will take place in Washington D.C., at the Walter E. Washington Convention Center, September 26-28, and the deadline to apply to present to strategic partners, venture capital firms and angel investors is July 11.Continue reading